Status:
COMPLETED
Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Conditions:
Acne
Eligibility:
All Genders
18-30 years
Phase:
PHASE2
Brief Summary
* Acne vulgaris is a common inflammatory skin disease that affects more than 85% of teens and some people may continue throughout adulthood. * Topical retinoids related to oral antibiotics are conside...
Detailed Description
* There will be a randomized, controlled, single blind comparison study of PDT with 5-aminolevulinic acid (ALA) 20% versus conventional therapy consisting of topical 0.1% adapalene plus doxycycline 10...
Eligibility Criteria
Inclusion
- Men and women between 18 and 30 years of age with moderate inflammatory acne
Exclusion
- Those who have received any treatment for acne either topic in the last 3 months before and systemic (including ACO started) in the last 6 months of the study.
- Patients who are pregnant or breastfeeding.
- Patients with history of photosensitivity or autoimmune disease.
- Patients with a history or active TB disease or HIV.
- Patient refusal to participate in the study.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01245946
Start Date
October 1 2010
End Date
May 1 2011
Last Update
June 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departamento de dermatología, Centro Médico San Joaquín, Pontificia Universidad Católica de Chile
Santiago, San Joaquín, Chile, 1234